GLP-1 in Perimenopause: What to Eat So Weight Loss Holds

The pen sits in the fridge door next to the oat milk, and for the first four months the GLP-1 does what the leaflet says. A woman of 46 eats half of what she ate in spring and the scale follows. Then the hot flushes arrive, she is awake at three most nights, and the scale slows while her waist fits worse than the number suggests. Perimenopause has started in the middle of the course, and the drug has not changed.

Whether you take Ozempic, Wegovy or Mounjaro is a decision for you and your prescriber. This article covers the part a prescription does not: what you eat and lift while the drug works, so the loss is mostly fat and holds once the dose changes or stops.

01

Why perimenopause changes the GLP-1 equation

A GLP-1 works the same at 47 as at 35: the appetite goes and the intake halves. What is different at 47 is what the smaller intake lands on. The muscle has been going on its own since about 30, falling estrogen is moving fat toward the waist, and after a night of hot flushes whatever appetite is left wants toast.

Take muscle first. After about age 30, adults lose roughly 3 to 8 percent of muscle mass per decade, a figure Volpi and colleagues set out in 2004, and the rate picks up later.⁶ That is before any drug or diet. A woman of 47 is already on that slope when she starts semaglutide, and the drug does not know fat from muscle when it shrinks her intake.

Estrogen is doing something separate. As it declines, fat moves from hips and thighs toward the abdomen; the mechanics are in how to lose belly fat during menopause. A GLP-1 reduces total fat, the abdominal kind included, but it does not restore the muscle that was holding your metabolism up.

The appetite side is where sleep comes in. On a GLP-1 you eat perhaps half of what you used to, and perimenopausal sleep pulls the half you do eat toward toast. That is how a woman lands on 50 g of protein a day without noticing it has happened.

02

What the October 2026 GLP-1 studies actually say

The Menopause Society met in San Diego in October 2026, and with the EASD meeting a fortnight earlier it produced the results this article leans on. CagriSema works about as well in perimenopause as before it. Hormone therapy may add a little to semaglutide's effect, though that is unproven, and semaglutide on its own takes lean mass that does not come back by itself.

The drugs work across the transition

Novo Nordisk presented a post hoc analysis of REDEFINE 1 on 20 October 2026. Across 2,309 women, CagriSema produced an average weight loss of 25.0 percent at 68 weeks against 3.0 percent on placebo. In the 1,902 women who could be assigned a menopausal stage: premenopausal 26.7 percent, perimenopausal 24.8 percent, postmenopausal 23.1 percent, with placebo groups between 1.7 and 2.6 percent.¹

This is a company analysis done after the fact, with menopausal status inferred rather than measured, and Novo itself calls it hypothesis generating. CagriSema is not yet approved; an FDA decision is expected in the last quarter of 2026.¹ The numbers fall a little with each stage and the drug class keeps working at 45.

Hormone therapy may add a little

A Mayo Clinic team led by Dr Regina Castaneda followed about 3,900 women aged 45 and over for about two years. Women on semaglutide who also used menopause hormone therapy had lost about 11 percent of body weight at one year, against 9.5 percent on semaglutide alone.²

This is observational. Hormone therapy was not assigned, so the study cannot separate the hormones from everything else that differs between the two groups. Castaneda said the findings need prospective trials and that weight loss is not an indication for hormone therapy.² I agree with her. Ask your doctor about HT because of hot flushes and ruined sleep, and treat the 1.5 point gap on the scale as a side note.

The muscle cost is measurable

The number I want every woman on a GLP-1 to know came from EASD in early October. Regeneron reported a trial of 975 people, 64 percent women, testing a muscle-preserving antibody alongside semaglutide. The control arms matter here: on semaglutide plus placebo, lean mass fell 6.6 percent by 26 weeks and 7.3 percent by 52 weeks. Among those who stopped semaglutide at week 26, lean mass was still 2.4 percent below baseline 26 weeks later.³

One smaller study is hopeful. Omada Health reported that adults pairing a GLP-1 with its coaching program (a health coach, peer group and exercise plan) lost 6 percent of body weight in 12 weeks against 3.3 percent with usual care, with muscle percentage rising 0.6 points against 0.2. It was not randomized and the company sells the program, so treat it as a signal.⁴ It fits what I see in practice: the women who are still doing well after the dose comes down used the drug as the time to change how they eat.

03

The protein floor on a GLP-1 in perimenopause

Protein is the first thing I fix for a perimenopausal client on a GLP-1. The target is 1.2 to 1.6 g per kilogram of body weight per day, delivered as roughly 30 g at each main meal. For a 75 kg (165 lb) woman that is 90 to 120 g a day. On a halved appetite you hit it through the order you eat things in and how dense each item is, because volume is what you no longer have.

The daily range comes from Phillips, Chevalier and Leidy, who argued in 2016 that at least 1.2 to 1.6 g per kilogram is a better adult target than the older minimum.⁷ The 2025 joint advisory on nutrition during GLP-1 therapy, led by Mozaffarian, lists adequate protein and strength training among its eight priorities, proposes the same 1.2 to 1.6 g per kilogram during active weight loss, and says protein alone is probably not enough without strength work.⁹ Neither was written for perimenopause. I apply them because the problem they solve, keeping muscle while weight falls, is exactly the one a 47-year-old on semaglutide has.

According to Krista Konrada, certified nutritionist, the working rule is 30 g of protein at each of three main meals, eaten first, before the vegetables and long before the starch. If nausea stops you after a third of the plate, that third was the protein. A snack of 10 to 20 g covers the gap on small-appetite days.

The swaps for foods that sit badly are in foods to avoid on Ozempic.

04

Fiber and the nausea problem

Fiber matters twice here: it keeps you regular on a drug famous for constipation, and it steadies the afternoon slump perimenopause brings. The target is about 28 g a day, the US Daily Value, but on a GLP-1 you reach it slowly, from cooked rather than raw sources, with fluid between meals.⁸

A big raw salad is the textbook fiber meal and it is the wrong shape for a stomach that empties slowly, because it fills the small space you have with water and leaves. In REDEFINE 1, nausea affected 55 percent of people on CagriSema and constipation 30.7 percent, so both ends of the gut are in play at once.¹

My rule is 5 g at a time. Add roughly 5 g of fiber a week until you are near the target, and hold where you are in the rough week after a dose increase. Fiber without extra fluid makes constipation worse, so the water goes between meals, where it does not compete with the protein for room.

If nausea is winning, drop back: yogurt, broth with a little chicken, toast, a shake sipped over an hour. Two days like that are fine. A week of them, or vomiting you cannot stop, is a call to your prescriber, and the red-flag list is in what to eat on Ozempic to avoid side effects.

05

The muscle rule: protein timing and lifting

Protein alone does not keep muscle on a GLP-1. The other half is something heavy lifted twice a week, with a 30 g protein meal within a couple of hours of each session, because muscle stays where it is used. In perimenopause you need both, because the body is already losing muscle on its own and the drug halves what you eat on top of that.

The trial arms where lean mass fell 7.3 percent in a year had none of this, as far as the report says.³ The report does not describe any structured strength program or protein target in those arms; the number reflects the drug on its own. The Omada signal, muscle percentage edging up a little more under coaching, points the same way.⁴

Two sessions a week is the floor I give clients, and it is enough. Squats to a chair, a push against the wall or floor, a row with a band or a bag of shopping, a hinge at the hips with a kettlebell or a full watering can. Twenty-five minutes, twice, at the heavier end of what you can do with good form, on days when the injection has settled.

Timing is your normal 30 g meal within two hours of the session, and no extra shake unless that meal is not going to happen. Sleep matters as much, because muscle repairs at night and perimenopause is what is breaking the nights. Food cannot fix 3 a.m. waking, but 90 g of protein and a strength session on four hours of sleep still beats the same four hours with toast. The stress side of the waist is in how to reduce cortisol.

06

One day on a GLP-1 in perimenopause, written out

A working day for a woman of about 75 kg (165 lb) on a stable dose, landing near 110 g of protein and around 28 g of fiber across four small eating occasions. There are no calorie figures because the drug is already managing how much you eat. The plan manages what the little you eat is made of.

A full week built this way, with a shopping list and an injection-day version, is in the GLP-1 meal plan. For the same structure without a GLP-1, when the dose stops, move to the menopause meal plan.

07

What to ask your doctor

The medical decisions belong with your prescriber, so the most useful thing I can do is write down the questions I would take to the appointment.

What protein target is right for me? The 1.2 to 1.6 g per kilogram range is general. With kidney disease, diabetes medication alongside the GLP-1, or a history of disordered eating, the number and the whole plan need setting by someone with your notes.

Should we talk about hormone therapy for the hot flushes? Ask because of the hot flushes and the broken sleep. Any effect on weight is a side benefit, and the study that suggested one was observational and unconfirmed.²

What is the plan for coming off, and when? Appetite returns when the drug stops and lost muscle does not come back on its own.³ Knowing the timeline lets you build the habits while the drug is still making them easy.

Is the NAION eye finding relevant to me? A study in the Annals of Internal Medicine reported about 3 to 4 extra cases of a rare optic nerve condition, NAION, per 10,000 people on GLP-1 drugs over 18 months, without proving the drug causes it; the authors advise prompt eye assessment for any sudden vision change.⁵ Carry that sentence to your doctor rather than changing anything yourself.

Never adjust, pause or stop a dose because of an article, this one included.

08

What a plan cannot fix

Food reaches a lot here, and it is worth being exact about what it does not reach. A meal plan cannot stop hot flushes or mend sleep that breaks at three in the morning, and it has no say in whether you stay on the drug. The strength sessions are also not something a plan can do for you.

What it can do is make sure that when the scale moves, what leaves is mostly fat. It keeps the protein up so muscle has material and gets the fiber in without a bowl of raw cabbage, and the eating pattern you build on it is still there when appetite returns, which is the part the drug cannot give you.

The realistic timeline is weeks for the things you feel and months for body composition. The scale is the slowest signal of all, because muscle held and fat lost move in opposite directions on the same number. The longer view is in menopause weight gain.